FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Andrew Freedman

Research Profile

Geographic Areas

United States

Disorders

Genes & Molecular Sequences

Genes, p53

Physiology

Concepts & Ideas

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Joanne W Elena; Christine B Ambrosone; Rachel Ballard-Barbash; Smita Bhatia; James R Cerhan; Patricia Hartge; Rebecca S Heist; Lawrence H Kushi; Timothy L Lash; Lindsay M Morton; Kenan Onel; John P Pierce; Leslie L Robison; Julia H Rowland; Deborah Schrag; Thomas A Sellers; Daniela Seminara; Xiao-Ou Shu; Naoko I Simonds; Nancy E Thomas; Lois B Travis; Cornelia M Ulrich; Andrew N Freedman
Leveraging epidemiology and clinical studies of cancer outcomes: recommendations and opportunities for translational research.
Muin J Khoury; Britt C Reid; Scott Rogers; Sheri D Schully; Daniela Seminara; Andrew N Freedman; Elizabeth M Gillanders; Chinonye E Harvey; Christie Kaefer; Mukesh Verma
Frontiers in cancer epidemiology: a challenge to the research community from the Epidemiology and Genomics Research Program at the National Cancer Institute.
Erika A Waters; Timothy S McNeel; Worta McCaskill Stevens; Andrew N Freedman
Use of tamoxifen and raloxifene for breast cancer chemoprevention in 2010.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Andrew Freedman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Joanne W Elena; Christine B Ambrosone; Rachel Ballard-Barbash; Smita Bhatia; James R Cerhan; Patricia Hartge; Rebecca S Heist; Lawrence H Kushi; Timothy L Lash; Lindsay M Morton; Kenan Onel; John P Pierce; Leslie L Robison; Julia H Rowland; Deborah Schrag; Thomas A Sellers; Daniela Seminara; Xiao-Ou Shu; Naoko I Simonds; Nancy E Thomas; Lois B Travis; Cornelia M Ulrich; Andrew N Freedman
Leveraging epidemiology and clinical studies of cancer outcomes: recommendations and opportunities for translational research.
Journal of the National Cancer Institute 2013;105(2):85-94.
2012: Muin J Khoury; Britt C Reid; Scott Rogers; Sheri D Schully; Daniela Seminara; Andrew N Freedman; Elizabeth M Gillanders; Chinonye E Harvey; Christie Kaefer; Mukesh Verma
Frontiers in cancer epidemiology: a challenge to the research community from the Epidemiology and Genomics Research Program at the National Cancer Institute.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2012;21(7):999-1001.
2012: Erika A Waters; Timothy S McNeel; Worta McCaskill Stevens; Andrew N Freedman
Use of tamoxifen and raloxifene for breast cancer chemoprevention in 2010.
Breast cancer research and treatment 2012;134(2):875-80.
2012: Katrina A B Goddard; Muin J Khoury; William A Knaus; Gary H Lyman; Scott Ramsey; Sheri D Schully; Sean R. Tunis; Heather Spencer Feigelson; Andrew N Freedman; Evelyn P. Whitlock; David L Veenstra
Building the evidence base for decision making in cancer genomic medicine using comparative effectiveness research.
Genetics in medicine : official journal of the American College of Medical Genetics 2012;14(7):633-42.
2011: Muin J Khoury; William M P Klein; Steven B Clauser; Andrew N Freedman; Elizabeth M Gillanders; Russ E Glasgow; Sheri D Schully
Population sciences, translational research, and the opportunities and challenges for genomics to reduce the burden of cancer in the 21st century.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2011;20(10):2105-14.
2011: A Cecile J W Janssens; Sara Bedrosian; Paolo Boffetta; Siobhan M Dolan; Nicole Dowling; Isabel Fortier; Andrew N Freedman; Jeremy M Grimshaw; Jeffrey Gulcher; Marta Gwinn; Mark A Hlatky; John Ioannidis; Holly Janes; Peter Kraft; Julian Little; Stephanie Melillo; Christopher J O'Donnell; Michael J Pencina; David Ransohoff; Sheri D Schully; Daniela Seminara; Cornelia M van Duijn; Deborah M Winn; Caroline F Wright; Muin J Khoury
Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration.
European journal of clinical investigation 2011;41(9):1010-35.
2011: A Cecile J W Janssens; Sara Bedrosian; Paolo Boffetta; Siobhan M Dolan; Nicole Dowling; Isabel Fortier; Andrew N Freedman; Jeremy M Grimshaw; Jeffrey Gulcher; Marta Gwinn; Mark A Hlatky; John Ioannidis; Holly Janes; Peter Kraft; Julian Little; Stephanie Melillo; Christopher J O'Donnell; Michael J Pencina; David Ransohoff; Sheri D Schully; Daniela Seminara; Cornelia M van Duijn; Deborah M Winn; Caroline F Wright; Muin J Khoury
Strengthening the reporting of Genetic RIsk Prediction Studies (GRIPS): explanation and elaboration.
Journal of clinical epidemiology 2011;64(8):e1-e22.
2011: Andrew N Freedman; Mitchell H Gail; Barry I Graubard; Garnet L Anderson; Joseph P Costantino; Victor G Vogel; Binbing Yu; Worta McCaskill-Stevens
Benefit/risk assessment for breast cancer chemoprevention with raloxifene or tamoxifen for women age 50 years or older.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(17):2327-33.
2011: Margaret R Spitz; Neil E Caporaso; Andrew N Freedman
Epidemiology--found in translation.
Cancer discovery 2011;1(1):21-2.
2010: Andrew N Freedman; Leah B Sansbury; William D Figg; Arnold L Potosky; Sheila Weiss Smith; Muin J Khoury; Stefanie A Nelson; Richard M Weinshilboum; Mark J Ratain; Howard L McLeod; Robert S Epstein; Geoffrey S Ginsburg; Richard L Schilsky; Geoffrey Liu; David A Flockhart; Cornelia M Ulrich; Robert L Davis; Lawrence J Lesko; Issam Zineh; Gurvaneet Randhawa; Christine B Ambrosone; Mary V Relling; Nat Rothman; Heng Xie; Margaret R Spitz; Rachel Ballard-Barbash; James H Doroshow; Lori M Minasian
Cancer pharmacogenomics and pharmacoepidemiology: setting a research agenda to accelerate translation.
Journal of the National Cancer Institute 2010;102(22):1698-705.
2010: Maren T Scheuner; Timothy S McNeel; Andrew N Freedman
Population prevalence of familial cancer and common hereditary cancer syndromes. The 2005 California Health Interview Survey.
Genetics in medicine : official journal of the American College of Medical Genetics 2010;12(11):726-35.
2010: Erika A Waters; Kathleen A Cronin; Barry I Graubard; Paul K J Han; Andrew N Freedman
Prevalence of tamoxifen use for breast cancer chemoprevention among U.S. women.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2010;19(2):443-6.
2009: Paul K J Han; William M P Klein; Thomas C Lehman; Holly Massett; Simon C Lee; Andrew N Freedman
Laypersons' responses to the communication of uncertainty regarding cancer risk estimates.
Medical decision making : an international journal of the Society for Medical Decision Making 2009;29(3):391-403.
2009: Paul K J Han; Thomas C Lehman; Holly Massett; Simon J C Lee; William M P Klein; Andrew N Freedman
Conceptual problems in laypersons' understanding of individualized cancer risk: a qualitative study.
Health expectations : an international journal of public participation in health care and health policy 2009;12(1):4-17.
2009: Andrew N Freedman; Martha L Slattery; Rachel Ballard-Barbash; Gordon Willis; Bette J Cann; David Pee; Mitchell H Gail; Ruth M Pfeiffer
Colorectal cancer risk prediction tool for white men and women without known susceptibility.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(5):686-93.
2005: Louise Wideroff; Susan T Vadaparampil; Mark H Greene; Stephen H Taplin; Lorayn Olson; Andrew N Freedman
Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians.
Journal of medical genetics 2005;42(10):749-55.
2005: Andrew N Freedman; Daniela Seminara; Mitchell H Gail; Patricia Hartge; GRaham Colditz; Rachel Ballard-Barbash; Ruth M Pfeiffer
Cancer risk prediction models: a workshop on development, evaluation, and application.
Journal of the National Cancer Institute 2005;97(10):715-23.
2005: Susan T Vadaparampil; Louise Wideroff; Lorayn Olson; Kasisomayajula V Viswanath; Andrew N Freedman
Physician exposure to and attitudes toward advertisements for genetic tests for inherited cancer susceptibility.
American journal of medical genetics. Part A 2005;135(1):41-6.
2005: Louise Burke; Douglas B Flieder; Donald G Guinee; Elizabeth Brambilla; Andrew N Freedman; Patrick Williams; Raymond T Jones; Andrew Borkowski; Neil A Caporaso; Marian Fleming; Victor Trastek; Peter C Pairolero; Henry D Tazelaar; David E Midthun; James R Jett; Lance A Liotta; William D Travis; Curtis C Harris
Prognostic implications of molecular and immunohistochemical profiles of the Rb and p53 cell cycle regulatory pathways in primary non-small cell lung carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(1):232-41.
2004: William Rakowski; Nancy Breen; Helen Meissner; Barbara K Rimer; Sally W Vernon; Melissa A Clark; Andrew N Freedman
Prevalence and correlates of repeat mammography among women aged 55-79 in the Year 2000 National Health Interview Survey.
Preventive medicine 2004;39(1):1-10.
2004: K Robin Yabroff; Nancy Breen; Sally W Vernon; Helen I Meissner; Andrew N Freedman; Rachel Ballard-Barbash
What factors are associated with diagnostic follow-up after abnormal mammograms? Findings from a U.S. National Survey.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2004;13(5):723-32.
2004: Asad Umar; C Richard Boland; Jonathan P Terdiman; Sapna Syngal; Albert de La Chapelle; Josef Rüschoff; Richard Fishel; Noralane M Lindor; Lawrence J Burgart; Richard Hamelin; Stanley R Hamilton; Robert A Hiatt; Jeremy Jass; Annika Lindblom; Henry T Lynch; Paivi Peltomaki; Scott D Ramsey; Miguel A Rodriguez-Bigas; H F A Vasen; Ernest T Hawk; J Carl Barrett; Andrew N Freedman; sudhir srivastava
Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.
Journal of the National Cancer Institute 2004;96(4):261-8.
2003: Andrew N Freedman; Louise Wideroff; Lorayn Olson; William Davis; Carrie N Klabunde; K P Srinath; Bryce B Reeve; Robert T Croyle; Rachel Ballard-Barbash
US physicians' attitudes toward genetic testing for cancer susceptibility.
American journal of medical genetics. Part A 2003;120A(1):63-71.
2003: Andrew N Freedman; Barry I Graubard; Sowmya R Rao; Worta McCaskill-Stevens; Rachel Ballard-Barbash; Mitchell H Gail
Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention.
Journal of the National Cancer Institute 2003;95(7):526-32.
2003: Louise Wideroff; Andrew N Freedman; Lorayn Olson; Carrie N Klabunde; William Davis; Kadaba P Srinath; Robert T Croyle; Rachel Ballard-Barbash
Physician use of genetic testing for cancer susceptibility: results of a national survey.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2003;12(4):295-303.
2003: Louise Wideroff; Susan T Vadaparampil; Nancy Breen; Robert T Croyle; Andrew N Freedman
Awareness of genetic testing for increased cancer risk in the year 2000 National Health Interview Survey.
Community genetics 2003;6(3):147-56.
1999: Rebecca Troisi; Andrew N Freedman; Susan S Devesa
Incidence of colorectal carcinoma in the U.S.: an update of trends by gender, race, age, subsite, and stage, 1975-1994.
Cancer 1999;85(8):1670-6.
1999: Scott D Ramsey; Andrew N Freedman; Kristin Berry; M Robyn Andersen; N Urban
Prevalence of pedigrees suggestive of hereditary nonpolyposis colorectal cancer among a community sample of women eligible for screening mammography.
Community genetics 1999;2(4):173-8.
1999: Andrew N Freedman
Somatic alterations and metabolic polymorphisms.
IARC scientific publications 1999;(148):37-50.
1999: H M Heffner; Andrew N Freedman; JE Asirwatham; S B Lele
Prognostic significance of p53, PCNA, and c-erbB-2 in endometrial enocarcinoma.
European journal of gynaecological oncology 1999;20(1):8-12.
1998: L Burke; Mohammed A Khan; Andrew N Freedman; A Gemma; Marek Rusin; Donald G Guinee; Patrick Williams; Neil E Caporaso; MV Fleming; William D Travis; T V Colby; Victor Trastek; Peter C Pairolero; Henry D Tazelaar; David E Midthun; Lance A Liotta; Curtis C Harris
Allelic deletion analysis of the FHIT gene predicts poor survival in non-small cell lung cancer.
Cancer research 1998;58(12):2533-6.
1998: Patrick Williams; Wafik S El-Deiry; WALTER RUSH; Donald G Guinee; Andrew N Freedman; Neil E Caporaso; Judith A Welsh; Raymond T Jones; Andrew Borkowski; William D Travis; MV Fleming; Victor Trastek; Peter C Pairolero; Henry D Tazelaar; David E Midthun; James R Jett; Lance A Liotta; Curtis C Harris
p21waf1/cip1 and transforming growth factor beta 1 protein expression correlate with survival in non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(6):1499-506.
1998: Andrew N Freedman; A M Michalek; H A Weiss; Z F Zhang; J R Marshall; CJ Mettlin; JE Asirwatham; N J Petrelli; Neil E Caporaso
Aspirin use and p53 expression in colorectal cancer.
Cancer detection and prevention 1998;22(3):213-8.
1998: MV Fleming; Donald G Guinee; Wei-Sing Chu; Andrew N Freedman; Neil E Caporaso; Patrick Williams; T V Colby; Henry D Tazelaar; Susan L Abbondanzo; James Jett; Peter C Pairolero; Victor Trastek; Lance A Liotta; Curtis C Harris; William D Travis
Bcl-2 immunohistochemistry in a surgical series of non-small cell lung cancer patients.
Human pathology 1998;29(1):60-4.
1997: Andrew N Freedman; A M Michalek; Rebecca Troisi; CJ Mettlin; N J Petrelli; JE Asirwatham; Neil Caporaso
Oral contraceptives, reproductive factors and p53 gene expression in colorectal cancer.
Carcinogenesis 1997;18(4):855-6.
1996: Arthur M Michalek; Germaine M Buck; Philip C Nasca; Andrew N Freedman; M S Baptiste; Martin C Mahoney
Gravid health status, medication use, and risk of neuroblastoma.
American journal of epidemiology 1996;143(10):996-1001.
1996: Andrew N Freedman; Arthur M Michalek; James R Marshall; C J Mettlin; N J Petrelli; Jennifer D Black; Z F Zhang; S Satchidanand; J E Asirwatham
Familial and nutritional risk factors for p53 overexpression in colorectal cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1996;5(4):285-91.
1996: Andrew N Freedman; Arthur M Michalek; James R Marshall; C J Mettlin; N J Petrelli; Z F Zhang; Jennifer D Black; S Satchidanand; J E Asirwatham
The relationship between smoking exposure and p53 overexpression in colorectal cancer.
British journal of cancer 1996;73(8):902-8.